HOME > ARCHIVE
ARCHIVE
- Health Economics Status Survey: Pharmacies' Profits Rose 7.6%
November 14, 2005
- R&D NEWS IN BREIF
November 14, 2005
- Are Medical Professionals' Incomes Acceptable?
November 14, 2005
- Eiken Chemical to Build Production Base in China
November 14, 2005
- REGULATORY NEWS IN BRIEF
November 14, 2005
- Korosho Proposes Discussion Topics for Reform of Med. Materials Pricing
November 14, 2005
- Mid-2006 Submission Envisioned for Parkinson's Disease Treatment: Kyowa Hakko
November 14, 2005
- NBI, Pfizer Japan: Survey Finds Little Awareness of COPD
November 14, 2005
- BUSINESS NEWS IN BRIEF
November 14, 2005
- AstraZeneca to Support Lung Cancer Awareness
November 14, 2005
- Takeda: Ethical Drug Sales Up 8.8% at \500,900 Mil.
November 14, 2005
- Eisai: Record Sales, Profits; Overseas Sales Break 50%
November 14, 2005
- Santen: Ethical Drugs Drive Growth in Sales, Profits
November 14, 2005
- Torii: Sales, Profits Hit by Slump in Major Products, TachoComb Transfer
November 14, 2005
- Japan Tobacco: Pharma Division Sales Down 0.8%
November 14, 2005
- President Dr Aoki Outlines JPMA's Stance on NHI Pricing
November 14, 2005
- Teijin: Sales of Medical and Pharmaceuticals Business Rise 8.8% to Top \51,600 Mil.
November 14, 2005
- Jiro Kawasaki Appointed Minister of Health, Labor and Welfare
November 14, 2005
- Wyeth's Anticancer Drug Pipeline Outlined
November 14, 2005
- Pharma Industry Has Steadily Increased Added Value: OPIR Report
November 7, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
